Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, August 2008, p. 2992-2993, Vol. 52, No. 8
0066-4804/08/$08.00+0 doi:10.1128/AAC.01686-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
Coprevalence of Plasmid-Mediated Quinolone Resistance Determinants QepA, Qnr, and AAC(6')-Ib-cr among 16S rRNA Methylase RmtB-Producing Escherichia coli Isolates from Pigs

LETTER
Plasmid-mediated quinolone resistance determinants, including
Qnr peptides and AAC(6')-Ib-cr, are increasingly identified
worldwide among various clinical isolates of
Enterobacteriaceae (
7,
9,
10). Very recently, a novel plasmid-mediated fluoroquinolone-resistant
determinant, QepA (quinolone efflux pump), which showed a considerable
similarity to the major facilitator superfamily-type efflux
pumps, was first identified in an
Escherichia coli clinical
isolate from Japan (
13) and later found also in an
E. coli isolate
in Belgium (
6). Interestingly, both of the two
qepA-harboring
E. coli isolates also contained the
rmtB gene encoding a 16S
rRNA methyltransferase, an emerging new molecular mechanism
responsible for high-level pan-aminoglycoside resistance among
gram-negative pathogens (
3,
4,
6,
13,
14).
Our previous study showed that rmtB was highly prevalent among E. coli isolates from pigs in China (1). The aim of this study was to investigate the prevalence of plasmid-mediated quinolone resistance determinants among rmtB-producing E. coli isolates from pigs in China and to identify the association of the qepA gene with rmtB.
One hundred fifty-one E. coli isolates were obtained from pig feces sampled at two pig farms. These isolates were collected from 2005 to 2006, and 48 of them were identified as producers of RmtB. (Some of these data were published previously [1].) Screening for qepA, qnrA, qnrB, qnrS, and aac(6')-Ib-cr genes was carried out by PCR amplification among the 48 rmtB-positive isolates. For qepA, the following primers were used to produce a 218-bp amplicon: qepA-F (5'-GCAGGTCCAGCAGCGGGTAG-3') and qepA-R (5'-CTTCCTGCCCGAGTATCGTG-3'). Positive results were confirmed by direct sequencing of PCR products. qnrA, qnrB, qnrS, and aac(6')-Ib-cr genes were detected by PCR using specific primers (the used qnrB primers were able to detect almost all known qnrB alleles except qnrB8), as previously described (5, 8, 11), and were finally confirmed by sequencing of each PCR product.
Overall, qepA, qnrB, qnrS, and aac(6')-Ib-cr were detected in 28 (58.3%), 1 (2.1%), 9 (18.8%), and 6 (12.5%) of 48 RmtB-producing E. coli isolates, respectively (Table 1). The qnrB genes were identified as qnrB6 alleles by sequencing. The qnrS genes were confirmed as qnrS1 (four isolates) and qnrS2 (five isolates) alleles by sequencing. Four isolates with uniform pulsed-field gel electrophoresis (PFGE) patterns harbored qepA, qnrS2, and aac(6')-Ib-cr genes concurrently.
View this table:
[in this window]
[in a new window]
|
TABLE 1. Characteristics of E. coli isolates and transconjugants harboring rmtB, as well as qnr, qepA, and/or aac(6')-Ib-cr
|
To investigate the association of
rmtB and
qepA,
rmtB-positive
E. coli transconjugants described previously (
1) were subjected
to PCR amplification of
qepA, and all transconjugants that originated
from the 28
qepA-positive isolates selected with aminoglycoside
resistance were positive for the
qepA gene except one, suggesting
an strong linkage of
qepA with
rmtB. Two
rmtB-positive transconjugants
also harbored
qnrS1 or
qnrS2.
MICs of ciprofloxacin, enrofloxacin, levofloxacin, nalidixic acid, and norfloxacin for the 27 qepA-positive and 2 qnrS-positive transconjugants were determined by the agar dilution method according to CLSI guidelines (2). The increase (fold) in quinolone MICs for transconjugants compared with those of recipients is shown in Table 1. The MICs for transconjugants strongly indicated that qepA as well as qnrS conferred quinolone resistance, with a 4- to 32-fold increase in norfloxacin MICs and 1- to 32-fold increase in enrofloxacin and ciprofloxacin MICs. However, variations in the quinolone MICs for different transconjugants suggested that the QepA may be expressed at variable levels. Xu et al. (12) recently reported that different promoter strengths may cause the differences in qnrA expression levels and in ciprofloxacin MICs of different transconjugants. Further studies are needed to find out whether the wide range of MICs of quinolones for different qepA-harboring transconjugants depends on the diversities in qepA expression levels due to different promoter strengths. MICs of enrofloxacin for all isolates were also determined by the agar dilution method according to CLSI guidelines. As indicated in Table 1, most isolates were resistant to enrofloxacin (MIC,
2 µg/ml), but six isolates were susceptible to enrofloxacin.
This study shows the high prevalence of plasmid-mediated quinolone resistance determinants among E. coli isolates recovered from food-producing animals. A total of 58.3% (28/48) of rmtB-positive E. coli isolates harbored qepA gene, indicating a close relationship between qepA and rmtB, which has been reported in the previous studies (6, 13). This is also the first time three different plasmid-mediated quinolone resistance determinants (QepA, Qnr, and AAC(6')-Ib-cr) were identified in an E. coli strain. Coproduction of QepA, Qnr, AAC(6')-Ib-cr, and RmtB may well facilitate the survival of bacteria under selective pressure of antimicrobial agents in both veterinary and human clinical environments, and the resistance determinants in food-producing animals could be transmitted to humans via the food chain. Further spread of these resistance determinants among pathogenic microbes may occur in the near future. Thus, it is necessary to monitor and minimize the spread of such resistance determinants among hazardous bacteria in both humans and animals.

ACKNOWLEDGMENTS
We are grateful to Ming-Gui Wang (Division of Infectious Diseases,
Huashan Hospital, Fudan University) and Sheng Chen (Department
of Microbiology and Molecular Genetics, Medical College of Wisconsin)
for critically reading the manuscript.
This work was supported in part by research grants from the National Natural Science Foundation of China (30500373 and 30130140) and National Key Technology R&D Program of China (2006BAK02A03-5).

FOOTNOTES

Published ahead of print on 19 May 2008.


REFERENCES
1 - Chen, L., Z. L. Chen, J. H. Liu, Z. L. Zeng, J. Y. Ma, and H. X. Jiang. 2007. Emergence of RmtB methylase-producing Escherichia coli and Enterobacter cloacae isolates from pigs in China. J. Antimicrob. Chemother. 59:880-885.[Abstract/Free Full Text]
2 - Clinical and Laboratory Standards Institute. 2002. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals. Approved standard, 2nd ed. Document M31-A2. CLSI, Wayne, PA.
3 - Doi, Y., and Y. Arakawa. 2007. 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides. Clin. Infect. Dis. 45:88-94.[CrossRef][Medline]
4 - Doi, Y., K. Yokoyama, K. Yamane, J.-I. Wachino, N. Shibata, T. Yagi, K. Shibayama, H. Kato, and Y. Arakawa. 2004. Plasmid-mediated 16S rRNA methylase in Serratia marcescens conferring high-level resistance to aminoglycosides. Antimicrob. Agents Chemother. 48:491-496.[Abstract/Free Full Text]
5 - Park, C. H., A. Robicsek, G. A. Jacoby, D. Sahm, and D. C. Hooper. 2006. Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob. Agents Chemother. 50:3953-3955.[Abstract/Free Full Text]
6 - Périchon, B., P. Courvalin, and M. Galimand. 2007. Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli. Antimicrob. Agents Chemother. 51:2464-2469.[Abstract/Free Full Text]
7 - Robicsek, A., G. A. Jacoby, and D. C. Hooper. 2006. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect. Dis. 6:629-640.[CrossRef][Medline]
8 - Robicsek, A., J. Strahilevitz, D. F. Sahm, G. A. Jacoby, and D. C. Hooper. 2006. qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob. Agents Chemother. 50:2872-2874.[Abstract/Free Full Text]
9 - Robicsek, A., J. Strahilevitz, G. A. Jacoby, M. Macielag, D. Abbanat, C. H. Park, K. Bush, and D. C. Hooper. 2006. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat. Med. 12:83-88.[CrossRef][Medline]
10 - Tran, J. H., and G. A. Jacoby. 2002. Mechanism of plasmid-mediated quinolone resistance. Proc. Natl. Acad. Sci. USA 99:5638-5642.[Abstract/Free Full Text]
11 - Wu, J.-J., W.-C. Ko, S.-H. Tsai, and J.-J. Yan. 2007. Prevalence of plasmid-mediated quinolone resistance determinants QnrA, QnrB, and QnrS among clinical isolates of Enterobacter cloacae in a Taiwanese hospital. Antimicrob. Agents Chemother. 51:1223-1227.[Abstract/Free Full Text]
12 - Xu, X., S. Wu, X. Ye, Y. Liu, W. Shi, Y. Zhang, and M. Wang. 2007. Prevalence and expression of the plasmid-mediated quinolone resistance determinant qnrA1. Antimicrob. Agents Chemother. 51:4105-4110.[Abstract/Free Full Text]
13 - Yamane, K., J. Wachino, S. Suzuki, K. Kimura, N. Shibata, H. Kato, K. Shibayama, T. Konda, and Y. Arakawa. 2007. New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Antimicrob. Agents Chemother. 51:3354-3360.[Abstract/Free Full Text]
14 - Yokoyama, K., Y. Doi, K. Yamane, H. Kurokawa, N. Shibata, K. Shibayama, T. Yagi, H. Kato, and Y. Arakawa. 2003. Acquisition of 16S rRNA methylase gene in Pseudomonas aeruginosa. Lancet 362:1888-1893.[CrossRef][Medline]
| | | | | |
Jian-Hua Liu
Yu-Ting Deng
Zhen-Ling Zeng
Jun-Hua Gao
College of Veterinary Medicine South China Agricultural University Guangzhou 510642, People's Republic of China
Lin Chen
College of Jiangsu Animal Health and Veterinary Science Taizhou 225300, People's Republic of China
Yoshichika Arakawa*
Department of Bacterial Pathogenesis and Infection Control National Institute of Infectious Diseases Tokyo, Japan
Zhang-Liu Chen
College of Veterinary Medicine South China Agricultural University Guangzhou 510642, People's Republic of China
|
| | | | | |
* Phone: 81-42-561-0771, ext. 500 Fax: 81-42-561-7173 E-mail: yarakawa{at}nih.go.jp
Phone: 86-20-85280237-808 Fax: 86-20-85284896 E-mail: scaupharm{at}163.com |
Antimicrobial Agents and Chemotherapy, August 2008, p. 2992-2993, Vol. 52, No. 8
0066-4804/08/$08.00+0 doi:10.1128/AAC.01686-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Strahilevitz, J., Jacoby, G. A., Hooper, D. C., Robicsek, A.
(2009). Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat. Clin. Microbiol. Rev.
22: 664-689
[Abstract]
[Full Text]
-
Fortini, D., Garcia-Fernandez, A., Veldman, K., Mevius, D., Carattoli, A.
(2009). Novel genetic environment of plasmid-mediated quinolone resistance gene qnrB2 in Salmonella Bredeney from poultry. J Antimicrob Chemother
0: dkp356v1-dkp356
[Full Text]
-
Sjolund-Karlsson, M., Folster, J. P., Pecic, G., Joyce, K., Medalla, F., Rickert, R., Whichard, J. M.
(2009). Emergence of Plasmid-Mediated Quinolone Resistance among Non-Typhi Salmonella enterica Isolates from Humans in the United States. Antimicrob. Agents Chemother.
53: 2142-2144
[Abstract]
[Full Text]
-
Ma, J., Zeng, Z., Chen, Z., Xu, X., Wang, X., Deng, Y., Lu, D., Huang, L., Zhang, Y., Liu, J., Wang, M.
(2009). High Prevalence of Plasmid-Mediated Quinolone Resistance Determinants qnr, aac(6')-Ib-cr, and qepA among Ceftiofur-Resistant Enterobacteriaceae Isolates from Companion and Food-Producing Animals. Antimicrob. Agents Chemother.
53: 519-524
[Abstract]
[Full Text]
-
Wu, C.-M., Wang, Y., Cao, X.-Y., Lin, J.-C., Qin, S.-S., Mi, T.-J., Huang, S.-Y., Shen, J.-Z.
(2009). Emergence of plasmid-mediated quinolone resistance genes in Enterobacteriaceae isolated from chickens in China. J Antimicrob Chemother
63: 408-411
[Full Text]
-
Park, Y.-J., Yu, J. K., Kim, S.-I., Lee, K., Arakawa, Y.
(2009). Accumulation of Plasmid-Mediated Fluoroquinolone Resistance Genes, qepA and qnrS1, in Enterobacter aerogenes Co-producing RmtB and Class A {beta}-lactamase LAP-1. Annals of Clinical & Laboratory Science
39: 55-59
[Abstract]
[Full Text]